Literature DB >> 8098519

Incidence and management of glaucoma in Vogt-Koyanagi-Harada syndrome.

D J Forster1, N A Rao, R A Hill, Q H Nguyen, G Baerveldt.   

Abstract

BACKGROUND: The Vogt-Koyanagi-Harada syndrome is a bilateral panuveitis associated with neurologic and dermatologic manifestations.
METHODS: The authors reviewed the charts of all patients with Vogt-Koyanagi-Harada syndrome seen at their institution over the past decade to determine the incidence of glaucoma, as well as the results of medical and surgical therapy for glaucoma, in this group of patients.
FINDINGS: Of 42 patients diagnosed with Vogt-Koyanagi-Harada syndrome, evidence of glaucoma requiring either medical or surgical intervention occurred in 16 patients (38.1%). Of these, nine (56.3%) had open-angle glaucoma and seven (43.7%) had angle-closure secondary to pupillary block. In 5 (31.3%) of the 16 patients, medical therapy alone was sufficient to control intraocular pressure. Eleven patients (68.7%) required surgical intervention, consisting of laser iridotomy, surgical iridectomy, trabeculectomy with or without 5-fluorouracil, and/or Molteno implantation.
CONCLUSION: The relative success of each of these procedures in this group of patients is discussed. Glaucoma is a common complication in the Vogt-Koyanagi-Harada syndrome, and one that is often difficult to control.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8098519     DOI: 10.1016/s0161-6420(93)31604-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  10 in total

1.  High prevalence of angle-closure glaucoma in Vogt-Koyanagi-Harada disease.

Authors:  Carlos Alvarez-Guzman; Jorge E Valdez-Garcia; Raul E Ruiz-Lozano; Alejandro Rodriguez-Garcia; Carlos F Navas-Villar; Curt Hartleben-Matkin; Miguel Pedroza-Seres
Journal:  Int Ophthalmol       Date:  2022-07-05       Impact factor: 2.031

2.  Effect of TNF, IL-1, and IL-6 on the proliferation of human Tenon's capsule fibroblasts in tissue culture.

Authors:  I A Cunliffe; P S Richardson; R C Rees; I G Rennie
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

3.  Prognostic factors in Vogt-Koyanagi-Harada disease.

Authors:  Abdullah S Al-Kharashi; Hassan Aldibhi; Hamad Al-Fraykh; Dustan Kangave; Ahmed M Abu El-Asrar
Journal:  Int Ophthalmol       Date:  2007-04-14       Impact factor: 2.029

4.  Vogt-Koyanagi-Harada disease in Hispanic patients.

Authors:  Somsiri Sukavatcharin; Julie H Tsai; Narsing A Rao
Journal:  Int Ophthalmol       Date:  2007-03-23       Impact factor: 2.029

Review 5.  Vogt-Koyanagi-Harada syndrome - current perspectives.

Authors:  Abeir Baltmr; Sue Lightman; Oren Tomkins-Netzer
Journal:  Clin Ophthalmol       Date:  2016-11-24

6.  Changes in Anterior Segment Morphology of Iris Bombe before and after Laser Peripheral Iridotomy in Patients with Uveitic Secondary Glaucoma.

Authors:  Wakako Ikegawa; Takashi Suzuki; Koji Namiguchi; Shiro Mizoue; Atsushi Shiraishi; Yuichi Ohashi
Journal:  J Ophthalmol       Date:  2016-10-31       Impact factor: 1.909

7.  The Effect of Perioperative Uveitis Control on the Success of Glaucoma Surgery in Uveitic Glaucoma.

Authors:  Moustafa S Magliyah; Abdulrahman H Badawi; Abdulaziz A Alshamrani; Rizwan Malik; Hassan Al-Dhibi
Journal:  Clin Ophthalmol       Date:  2021-04-09

8.  Influence of early cerebrospinal fluid-guided diagnosis and early high-dose corticosteroid therapy on ocular outcomes of Vogt-Koyanagi-Harada disease.

Authors:  Masaru Miyanaga; Tatushi Kawaguchi; Kentaro Shimizu; Kazunori Miyata; Manabu Mochizuki
Journal:  Int Ophthalmol       Date:  2007-05-03       Impact factor: 2.029

Review 9.  Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes.

Authors:  Marcelo Mendes Lavezzo; Viviane Mayumi Sakata; Celso Morita; Ever Ernesto Caso Rodriguez; Smairah Frutuoso Abdallah; Felipe T G da Silva; Carlos Eduardo Hirata; Joyce Hisae Yamamoto
Journal:  Orphanet J Rare Dis       Date:  2016-03-24       Impact factor: 4.123

10.  Vitreous lavage fluid and bronchoalveolar lavage fluid have equal diagnostic value in sarcoidosis.

Authors:  Kazuichi Maruyama; Tohru Inaba; Tsutomu Tamada; Toru Nakazawa
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.